[1] 姜腾. 吡格列酮改善2型糖尿病大鼠脑内胰岛素抵抗以及阿尔茨海默病样tau蛋白磷酸化[D]. 武汉:华中科技大学,2013. [2] RüB U,STRATMANN K,HEINSEN H,et al. Alzheimer's disease:characterization of the brain sites of the initial tau cytoskeletal pathology will improve the success of novel immunological anti-tau treatment approaches[J]. J Alzheimer's Dis,2017,57(3):1-14. [3] GIACOBINI E,GOLD G. Alzheimer disease therapy-moving from amyloid-β to tau[J]. Nat Rev Neurol,2013,9(12):677-686. [4] SINGH S K,SRIKRISHNA S,CASTELLANI R J,et al. Antioxidants in the prevention and treatment of Alzheimer's Disease[M]//nutritional antioxidant therapies:Treatments and perspectives. Berlin:Springer,2017:523-553. [5] ITTNER LM,GÖTZ J. Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease[J]. Nat Rev Neurosci,2011,12(2):65-72. [6] MOSZCZYNSKI A J,YANG W,HAMMOND R,et al. Threonine 175,a novel pathological phosphorylation site on tau protein linked to multiple tauopathies[J]. Acta Neuropathol Commun,2017,5(1):6. [7] CAO M,LIU F,JI F,et al. Effect of c-Jun N-terminal kinase (JNK)/p38 mitogen-activated protein kinase (p38 MAPK) in morphine-induced tau protein hyperphosphorylation[J]. Behav Brain Res,2013,237(2):249-255. [8] PERRON N R,BRUMAGHIM J L. A Review of the antioxidant mechanisms of polyphenol compounds related to iron binding[J]. Cell Biochem Biophys,2009,53(2):75-100. [9] HAYDEN E Y,YAMIN G,BEROUKHIM S,et al. Inhibiting amyloid β-protein assembly:Size-activity relationships among grape seed-derived polyphenols[J]. J Neurochem,2015,135(2):416. [10] RAM D,JENNIFER LR,YALE EG,et al. Differential regulation of dynein and kines in motor proteins by tau[J]. Science,2008,319(5866):1086-1089. [11] HORVATH J,BURKHARD P R,HERRMANN F R,et al. Neuropathology of parkinsonism in patients with pure Alzheimer's disease[J]. J Alzheimer's Dis,2014,39(1):115-120. [12] DE FELICE FG,WU D,LAMBERT MP,et al. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by a beta oligomers[J]. Neurobiol Aging,2008,29(9):1334-1347. [13] MUDHER A,LOVESTONE S. Alzheimer's disease-do tauists and baptists finally shake hands?[J]. Trends Neurosci,2002,25(1):22. [14] CARDOSO S M,SANTANA I,SWERDLOW R H,et al. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity[J]. J Neurochem,2004,89(6):1417-1426. [15] HANGER DP,ANDERTON BH,NOBLE W. Tau phosphorylation:the therapeutic challenge for neurodegenerative disease[J]. Trends Mol Med,2009,15(3):112-119. [16] XU W,YANG L,LI J. Protection against β-amyloid-induced neurotoxicity by naturally occurring z-ligustilide through the concurrent regulation of p38 and PI3-K/Akt pathways[J]. Neurochem Int,2016,100:44-51. [17] KIM H,YOUN K,AHN MR,et al. Neuroprotective effect of loganin against Aβ25-35-induced injury via the NF-κB-dependent signaling pathway in PC12 cells[J]. Food Funct,2015,6(4):1108-1116. [18] GIRALDO E,LLORET A,FUCHSBERGER T,et al. Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation:Protective role of vitamin E[J]. Redox Biol,2014,2:873-877. |